Alexander Chernavin

Biography:

Alexander Chernavin graduated from Volgograd State Medical University in 1998 with a specialization in pediatrics. Following his initial studies, he pursued further training and work in the fields of allergology-immunology, bacteriology, and clinical pharmacology, eventually earning a PhD. His career in the pharmaceutical industry began in 2003, during which he held positions at various Russian and international companies, including Materia Medica, Microgen, Sanofi-Aventis, and Sandoz.

Since April 2014, he has been associated with R-Pharm in Moscow, where he has held multiple roles. In October 2020, he assumed the position of Regional Medical Director, overseeing operations in Russia and CIS countries. His expertise spans a wide range of therapeutic areas, including infectious diseases (antibiotics, tuberculosis, antifungals, virology/vaccines), immunology, blood products, intensive care and anesthesiology, urology, pulmonology, cardiology, nephrology, rare diseases, radiology, nuclear medicine, laboratory diagnostics, and medical equipment. Additionally, his work extends to women's health, perinatal diagnostics, multiple sclerosis, endocrinology, ophthalmology, pre-wound healing drugs, and dietary supplements.